On the heels of the pandemic, the awareness, investments, and enthusiasm surrounding vaccine research is at an all-time high. At the same time, challenges in pushing vaccine trials forward remain, and many barriers are more palpable now than ever before.
These challenges partly stem from the sheer number of people required for vaccine trials. A large participant pool invites issues of scale as sponsors work to enroll more people while serving aims across DEI, logistics, patient compliance, and site selection.
In this report, we’ll speak with experts as we explore the latest challenges inherent in vaccine R&D, as well as the opportunities for sponsors, CROs, and other stakeholders to help solve them. The report will explore:
Thank you for your interest in the report. Click below to get your copy!Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again